Literature DB >> 23118491

First total synthesis of the (±)-2-methoxy-6-heptadecynoic acid and related 2-methoxylated analogs as effective inhibitors of the leishmania topoisomerase IB enzyme.

Néstor M Carballeira1, Michelle Cartagena, Fengyu Li, Zhongfang Chen, Christopher F Prada, Estefania Calvo-Alvarez, Rosa M Reguera, Rafael Balaña-Fouce.   

Abstract

The fatty acids (±)-2-methoxy-6Z-heptadecenoic acid (1), (±)-2-methoxy-6-heptadecynoic acid (2) and (±)-2-methoxyheptadecanoic acid (3) were synthesized and their inhibitory activity against the Leishmania DNA topoisomerase IB enzyme (LdTopIB) determined. Acids 1 and 2 were synthesized from 4-bromo-1-pentanol, the former in ten steps and in 7% overall yield, while the latter in seven steps and in 14% overall yield. Acid 3 was prepared in six steps and in 42% yield from 1-hexadecanol. Acids 1-3 inhibited the LdTopIB enzyme following the order 2 > 1 ⪢ 3, with 2 displaying an EC(50) = 16.6 ± 1.1 μM and 3 not inhibiting the enzyme. Acid 1 preferentially inhibited the LdTopIB enzyme over the human TopIB enzyme. Unsaturation seems to be a prerequisite for effective inhibition, rationalized in terms of weak intermolecular interactions between the active site of LdTopIB and either the double or triple bonds of the fatty acids. Toxicity towards Leishmania donovani promastigotes was also investigated resulting in the same order 2 > 1 > 3, with 2 displaying an EC(50) = 74.0 ± 17.1 μM. Our results indicate that α-methoxylation decreases the toxicity of C(17:1) fatty acids towards L. donovani promastigotes, but improves their selectivity index.

Entities:  

Year:  2012        PMID: 23118491      PMCID: PMC3483880          DOI: 10.1351/PAC-CON-11-10-21

Source DB:  PubMed          Journal:  Pure Appl Chem        ISSN: 0033-4545            Impact factor:   2.453


  12 in total

1.  The Cationminus signpi Interaction.

Authors:  Jennifer C. Ma; Dennis A. Dougherty
Journal:  Chem Rev       Date:  1997-08-05       Impact factor: 60.622

2.  Conjugated eicosapentaenoic acid inhibits human topoisomerase IB with a mechanism different from camptothecin.

Authors:  Silvia Castelli; Alessia Campagna; Oscar Vassallo; Cinzia Tesauro; Paola Fiorani; Pietro Tagliatesta; Francesco Oteri; Mattia Falconi; Hemanta K Majumder; Alessandro Desideri
Journal:  Arch Biochem Biophys       Date:  2009-05-04       Impact factor: 4.013

3.  Toxic effects of fatty acids on Leishmania donovani promastigotes.

Authors:  G Chaudhuri; K Ghoshal; A B Banerjee
Journal:  Indian J Med Res       Date:  1986-10       Impact factor: 2.375

4.  Effect of long-chain fatty acids on some trypanosomatid flagellates.

Authors:  L V Cunningham; B H Kazan; S S Kuwahara
Journal:  J Gen Microbiol       Date:  1972-05

Review 5.  Recent advances in leishmaniasis treatment.

Authors:  Tatiana S Tiuman; Adriana O Santos; Tânia Ueda-Nakamura; Benedito P Dias Filho; Celso V Nakamura
Journal:  Int J Infect Dis       Date:  2011-05-24       Impact factor: 3.623

6.  Identification and total synthesis of a novel dimethylated fatty acid from the Caribbean sponge Calyx podatypa.

Authors:  N M Carballeira; M Pagán
Journal:  J Nat Prod       Date:  2000-05       Impact factor: 4.050

7.  Central nervous system toxicity associated with liposomal amphotericin B therapy for cutaneous leishmaniasis.

Authors:  Jessie S Glasser; Clinton K Murray
Journal:  Am J Trop Med Hyg       Date:  2011-04       Impact factor: 2.345

8.  Total synthesis and antileishmanial activity of the natural occurring acetylenic fatty acids 6-heptadecynoic acid and 6-icosynoic acid.

Authors:  Néstor M Carballeira; Michelle M Cartagena; Christopher Fernández Prada; Celia Fernández Rubio; Rafael Balaña-Fouce
Journal:  Lipids       Date:  2009-09-30       Impact factor: 1.880

9.  A novel active DNA topoisomerase I in Leishmania donovani.

Authors:  Héctor Villa; Ana R Otero Marcos; Rosa M Reguera; Rafael Balaña-Fouce; Carlos García-Estrada; Yolanda Pérez-Pertejo; Babu L Tekwani; Peter J Myler; Kenneth D Stuart; Mary-Ann Bjornsti; David Ordóñez
Journal:  J Biol Chem       Date:  2002-11-19       Impact factor: 5.157

10.  Two cases of visceral leishmaniasis in Colombia resistant to meglumine antimonial treatment.

Authors:  Iván Darío Vélez; Lina María Colmenares; Carlos Aguirre Muñoz
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2009 Jul-Aug       Impact factor: 1.846

View more
  5 in total

1.  Novel Very Long-Chain α-Methoxylated Δ5,9 Fatty Acids from the Sponge Asteropus niger Are Effective Inhibitors of Topoisomerases IB.

Authors:  Néstor M Carballeira; Nashbly Montano; Luis A Amador; Abimael D Rodríguez; Mikhail Y Golovko; Svetlana A Golovko; Rosa M Reguera; Raquel Álvarez-Velilla; Rafael Balaña-Fouce
Journal:  Lipids       Date:  2015-12-22       Impact factor: 1.880

2.  First Total Synthesis of ω-Phenyl Δ6 Fatty Acids and their Leishmanicidal and Anticancer Properties.

Authors:  Nestor M Carballeira; Christian Morales-Guzman; Ester Alvarez-Benedicto; Zally Torres-Martinez; Yamixa Delgado; Kai H Griebenow; Arthur D Tinoco; Rosa M Reguera; Yolanda Perez-Pertejo; Ruben Carbajo-Andres; Rafael Balana-Fouce
Journal:  Curr Top Med Chem       Date:  2018       Impact factor: 3.295

3.  Synthesis of the novel (±)-2-methoxy-6-icosynoic acid--a fatty acid that induces death of neuroblastoma cells.

Authors:  Elsie A Orellano; Michelle M Cartagena; Karolyna Rosado; Néstor M Carballeira
Journal:  Chem Phys Lipids       Date:  2013-05-03       Impact factor: 3.329

4.  Synthesis of marine α-methoxylated fatty acid analogs that effectively inhibit the topoisomerase IB from Leishmania donovani with a mechanism different from that of camptothecin.

Authors:  Néstor M Carballeira; Nashbly Montano; Raquel Alvarez-Velilla; Christopher F Prada; Rosa M Reguera; Rafael Balaña-Fouce
Journal:  Mar Drugs       Date:  2013-09-30       Impact factor: 5.118

5.  Arrabidaea chica hexanic extract induces mitochondrion damage and peptidase inhibition on Leishmania spp.

Authors:  Igor A Rodrigues; Mariana M B Azevedo; Francisco C M Chaves; Celuta S Alviano; Daniela S Alviano; Alane B Vermelho
Journal:  Biomed Res Int       Date:  2014-04-09       Impact factor: 3.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.